TriSalus Life Sciences, Inc. (TLSI)
NASDAQHealth CareMedical - DevicesSnapshot 2026-09-04
$5.00+0.40%
Close 2026-09-04 · 1-day change
NASDAQHealth CareMedical - DevicesSnapshot 2026-09-04
QuarterlyIQ Insights · TLSI
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | FY 2020 | |
|---|---|---|---|---|---|---|---|
| Revenues | |||||||
| Revenues | 45.1 | 45.2 | 29.4 | 18.5 | 12.4 | — | — |
| Cost of Revenues | 6.4 | 7.0 | 4.1 | 2.6 | 2.3 | — | — |
| Gross Profit | 38.7 | 38.2 | 25.3 | 15.9 | 10.1 | — | — |
| Operating Expenses & Income | |||||||
| R&D Expenses | 14.6 | 15.0 | 17.7 | 29.8 | 21.4 | — | — |
| Operating Income | (30.5) | (26.9) | (36.2) | (54.5) | (36.4) | (3.0) | — |
| Earnings from Continuing Operations | |||||||
| Interest Expense | — | 5.5 | 3.1 | 0.0 | 0.0 | — | — |
| Interest & Investment Income | 1.0 | 0.6 | 0.4 | 0.4 | 0.2 | 0.1 | — |
| Net Interest Expenses | — | — | — | (0.4) | (0.2) | — | — |
| Other Non-Operating Income / Expenses | — | — | — | — | 8.9 | 7.8 | — |
| EBT, Incl. Unusual Items | (28.2) | (39.2) | (30.0) | (59.4) | (47.2) | 4.8 | — |
| Income Tax Expense | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — |
| Net Income | |||||||
| Net Income | (28.2) | (39.2) | (30.0) | (59.4) | (47.2) | 4.8 | — |
| Per Share | |||||||
| Basic EPS | (0.48) | (1.84) | (1.31) | (6.77) | (161.55) | — | — |
| Diluted EPS | (0.48) | (1.84) | (1.31) | (6.77) | (161.55) | — | — |
| Revenue per Share | 0.77 | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 58.3 | 37.9 | 25.3 | 9.4 | 0.3 | — | — |
| Diluted Weighted Avg Shares | 58.3 | 37.9 | 25.3 | 9.4 | 0.3 | — | — |
| Supplemental | |||||||
| EBITDA | — | (26.3) | (35.4) | (53.8) | (36.0) | — | — |
| EBIT | (30.5) | (26.9) | (36.2) | (54.5) | (36.4) | (3.0) | — |
| Effective Tax Rate | -0.0% | — | — | -0.0% | -0.0% | 0.0% | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.